LUGARESI, Alessandra
 Distribuzione geografica
Continente #
EU - Europa 8.529
NA - Nord America 7.946
AS - Asia 3.977
Continente sconosciuto - Info sul continente non disponibili 21
SA - Sud America 10
OC - Oceania 6
AF - Africa 5
Totale 20.494
Nazione #
US - Stati Uniti d'America 7.916
IT - Italia 2.147
UA - Ucraina 1.560
CN - Cina 1.553
IE - Irlanda 1.338
TR - Turchia 1.066
SG - Singapore 1.028
GB - Regno Unito 987
SE - Svezia 711
FR - Francia 640
DE - Germania 467
FI - Finlandia 333
RU - Federazione Russa 215
IN - India 200
IR - Iran 37
VN - Vietnam 34
CA - Canada 27
CZ - Repubblica Ceca 21
EU - Europa 21
BE - Belgio 20
JP - Giappone 18
IL - Israele 16
NL - Olanda 14
ES - Italia 13
GR - Grecia 10
PL - Polonia 10
DK - Danimarca 8
KR - Corea 8
AT - Austria 6
AU - Australia 6
BR - Brasile 6
MK - Macedonia 5
HK - Hong Kong 4
RS - Serbia 4
CH - Svizzera 3
EG - Egitto 3
HR - Croazia 3
LT - Lituania 3
MX - Messico 3
RO - Romania 3
TW - Taiwan 3
BD - Bangladesh 2
EC - Ecuador 2
LU - Lussemburgo 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
ME - Montenegro 1
MM - Myanmar 1
MZ - Mozambico 1
NO - Norvegia 1
PH - Filippine 1
TH - Thailandia 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 20.494
Città #
Jacksonville 1.782
Chandler 1.482
Dublin 1.327
Singapore 892
Southend 794
Princeton 616
Izmir 599
Nanjing 462
Wilmington 348
Cambridge 302
Beijing 250
Santa Clara 209
Ashburn 201
Altamura 199
Nanchang 181
Dearborn 157
Ann Arbor 150
Woodbridge 130
Boardman 96
Shenyang 93
Jiaxing 88
Milan 87
New York 84
Rome 83
Hebei 81
Chieti 75
Kunming 74
Tianjin 69
Norwalk 64
Houston 59
Grevenbroich 46
Hangzhou 45
Changsha 42
Los Angeles 41
San Mateo 39
Torino 39
Helsinki 35
Washington 34
Dong Ket 33
Bologna 31
Naples 31
Leawood 30
Ardabil 29
Florence 28
Augusta 25
Moscow 25
Orange 25
Turin 25
Bari 24
Jinan 24
Changchun 20
Lanzhou 20
Brno 18
Guangzhou 18
Verona 18
Pisa 17
Genoa 16
Brussels 15
Cedar Knolls 15
Monmouth Junction 15
Campobasso 14
London 14
Ningbo 14
Catania 13
Palermo 13
Toronto 13
Catanzaro 12
Genova 12
Hanover 12
Seattle 12
Zhengzhou 12
Falls Church 11
Munich 11
Auburn Hills 10
Frankfurt am Main 10
Casièr 9
Parma 9
Pescara 9
Poggio Picenze 9
Taizhou 9
Tappahannock 9
Venezia 8
Andover 7
Hefei 7
Massa E Cozzile 7
Mumbai 7
Napoli 7
Reggio Calabria 7
Teramo 7
Cagliari 6
Cazzago San Martino 6
Codogno 6
Montréal 6
Padova 6
Pavia 6
San Vito Chietino 6
Montesilvano Marina 5
Perugia 5
Piacenza 5
Portici 5
Totale 12.213
Nome #
La risposta simpatica cutanea: basi neurofisiologiche, valori normativi, applicazioni cliniche 1.322
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population 255
Ruolo degli anticorpi anti-gangliosidi nelle neuropatie e nelle malattie del motoneurone 188
Miastenia gravis "distale" e neuronopatia sensitiva simulanti una neuropatia sensori-motoria 185
Un caso di mieloneuropatia da HTLV- I in Italia 182
Polineuropatia assonale cronica progressiva sensibile al trattamento steroideo: una neuropatia assonale primitiva o una variante della poliradicoloneuropatia cronica ingiammatoria demielinizzante? 160
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 141
IL 13 in multiple sclerosis 120
Anti-GD1a Antibodies from Acute Motor Axonal Neuropathy Patients Selectively Bind to Ranvier Nodes of Motor Nerve Fibers 120
The brief international cognitive assessment for multiple sclerosis (bicams): normative values in the Italian population. 111
Cleavage of cystatin C is not associated with multiple sclerosis 108
Studio comparativo multicentrico sulla misurazione degli anticorpi IgM ANTI-GM1 nel siero di pazienti con neuropatia motoria multifocale e sclerosi laterale amiotrofica 105
Amplifications of multiple regions of the HTLV-I genome from DNA of an Italian spastic paraparesis patient but not from DNA of multiple sclerosis patients. 104
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Normative Values With Gender, Age And Education Corrections In The Italian Population (P5.015) 103
Utilità dell'ecobiometria del nervo ottico nella diagnosi e nel follow-up della neurite ottica retrobulbare 102
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 100
La funzione soppressoria è ridotta nella polineuropatia demielinizzante cronica infiammatoria (CIDP) 97
Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra 97
Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier 96
A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples 96
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 96
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) ASSOCIATED WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS 95
Utilità della tecnica destir (RM) nella diagnosi di neurite ottica retrobulbare 94
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 93
"Minimal" chronic inflammatory demyelinating polyneuropathy 92
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 91
F response in vascular and degenerative upper motor neuron lesions 91
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 91
Binding of Anti GD1 a Antibodies in Peripheral Nerve. Abstracts of the 4th Meeting of the Italian Peripheral Nerve Study Group - Chieti, March 26-27 1999 90
Anti-glycolipid and anti-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy 90
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 90
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 90
Dysimmune demyelinating polyneuropathies: expression of adhesion molecules in sural nerves and changes in cellular immunity (suppressor cell function and cytokine mRNA expression) induced by treatment (progetto presentato a Telethon) 89
Transdermal scopolamine cycloplegia in juvenile diabetes 89
Chronic inflammatory demyelinating polyneuropathy in diabetes 88
Adhesion molecule expression in sural nerve of chronic inflammatory demyelinating polineuropaty 88
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 88
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 87
Neurite ottica retrobulbare: studio biometrico del nervo ottico 86
Rantes and MCP-1 Secretion by Mononuclear Cells of Patients with Nultiple Sclerosis 86
Autoimmunity and interferon beta1B 85
Increasing age at disability milestones among MS patients in the MSBase Registry 85
Effect of TNF intraneural injection into the rat sciatic nerve 84
Interferon beta1b: the Chieti experience 83
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 83
Anti-ganglioside antibodies in the Guillain-Barré syndrome (GBS): a case control study 83
Recurrent cranial nerve palsies, midbrain infarction and hydrocephalus due to megadolichobasilar artery 83
Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei 83
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 83
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 82
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 82
May electrophysiology differentiate chronic inflammatory demyelinating polyneuropathy (CIDP) and polineuropathy with anti- SGPG antibodies? 82
Interferon beta normalizes suppressor cell function in dysimmune neuropathies. 82
Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy. 81
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. 81
Effects of IL10 on recombinant interferon-beta1b stimulated suppressor cell function in MS and controls subjects 80
Chronic inflammatory demyelinating polyneuropathy in diabetes mellitus 80
Acute motor conduction block neuropathy Another Guillain-Barré syndrome variant. 80
Effect of rhTNF-alpha injection into rat sciatic nerve 80
Neurite ottica: relazione tra perimetria, PEV e RMN 79
Plasma exchange and prednisone improve suppressor cell function in dysimmune neuropathies 79
Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation? 79
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 79
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 78
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis 77
Interferon therapy in dysimmune neuropathies 77
Anti-glicolipid antibodies in chronic inflammatory demyelinating polyneuropathy (CIDP) 76
Interferon beta normalizes suppressor cell function in dysimmune neuropathies 76
Serum soluble adhesion molecules and proinflammatory cytokines are not increased in chronic inflammatory demyelinating polyneuropathy 76
Patterns in patients’expression of emotions and neurologists’ response. 76
rlFN-beta-1B stimulated suppressor cell function in multiple sclerosis: effects of anti-IL-10 monoclonal antibody 75
Expression of adhesion molecules in sural nerve of chronic inflammatory demyelinating polyneuropathy (CIDP) 75
TheND1 gene of complex I is a mutational hot spot for Leber’s hereditary optic neuropathy 75
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis 75
Sclerosi multipla: meccanismi patogenetici alla base della demielinizzazione 75
Protein profiling of Guillain-Barrè Syndrome cerebrospinal fluid by two dimensional electrophoresis and mass spectrometry. 75
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 75
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis 75
Demyelinating motor Guillain-Barré syndrome following Rubella 75
Caratteristiche elettrofisiologiche della polineuropatia acuta assonale motoria associata ad elevato titolo di anticorpi anti-GD1a 74
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 74
Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis 74
Lack of vegetative and endocrine circadian rhythms in fatal familial thalamic degeneration 74
Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy 74
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 74
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 73
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 73
Extrapyramidal syndrome and depression induced by flunarizine 73
Chemokine secretion by mononuclear cells of patients with multiple sclerosis (MS) 72
Brain tissue loss occurs after suppression of enhancement in patients with multiple scerosis treated with autologous haematopoietic stem cell transplantation. 72
Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy? 72
CNS involvement in chronic inflammatory polyneuropathy. An electrophysiological and MRI study 72
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 72
Aspetti immunologici delle poliradicoloneuriti croniche 71
Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis 71
Comparative efficacy of switching to natalizumab in active multiple sclerosis 71
Shared T Cell Receptor Usage of Cerebrospinal Fluid Cells in Familial Multiple Sclerosis da: X° National A.I.N.I. Congress Association Italiana Neuroimmunologia - Florence, Italy, November 15/16,1999 71
Minimal and Ssymptomatic Chronic inflammatory demyelinating Polyneuropathy. da:Abstracts of the 4th Meeting of the Italian Peripheral Nerve Study Group- Chieti Marzo 26-27-1999 71
76.Distal myasthenia gravis and sensory neuronopathy with anti-50 kDa antibody mimicking sensory-motor neuropathy. 71
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 71
Totale 10.205
Categoria #
all - tutte 75.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.954


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.600 0 0 0 0 0 186 392 361 49 193 392 27
2020/20211.936 317 10 312 18 154 388 19 14 176 218 183 127
2021/20221.200 13 21 19 193 62 35 42 99 94 27 198 397
2022/20234.212 376 504 192 499 416 851 290 302 488 55 129 110
2023/20241.870 152 105 109 52 84 545 465 75 24 43 37 179
2024/20252.060 342 773 737 77 87 44 0 0 0 0 0 0
Totale 20.725